meetings

September 20, 2021 · Brielle Gregory Collins, ASCO staff
Read research highlights from the 2021 Quality Care Symposium, including a study on improving care for underserved people with cancer and a study investigating what causes delays in patients receiving their cancer medications. Read More >>
2021 ASCO Annual Meeting; #ASCO21
August 5, 2021 · Brielle Gregory Collins, ASCO staff
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer. Read More >>
July 8, 2021 · Jyoti Patel, MD, FASCO
In this month’s “From the Editor in Chief,” Dr. Jyoti Patel reflects on the 2021 ASCO Annual Meeting theme of equity, including what it means for people with cancer and how the cancer community is working to create equity in cancer care. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
La reunión anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) comenzará el 4 de junio y estas son algunas de las investigaciones destacadas que se presentarán. Los temas incluyen la inmunoterapia combinada para el cáncer de esófago, radioterapia dirigida para el CPRC metastásico, el olaparib para el cáncer de mama negativo para HER2, quimioterapia adyuvante para el cáncer de cuello uterino, el pembrolizumab para el cáncer de riñón y el toripalimab para el cáncer nasofaríngeo. Read More >>

Pages